A call for a global 'bigger' data approach to Alzheimer disease

Nat Rev Drug Discov. 2019 May;18(5):319-320. doi: 10.1038/nrd.2018.86.

Authors

Eric Perakslis^{1

2}, Henry Riordan³, Lawrence Friedhoff⁴, Azmi Nabulsi⁵, Emilio Merlo Pich⁶

Affiliations

¹ Datavant Inc., San Franciso, CA, USA. eric@datavant.com.
² Harvard Medical School, Boston, MA, USA. eric@datavant.com.
³ Worldwide Clinical Trials Medical and Scientific Affairs Morrisville, NC, USA.
⁴ Roivant Sciences Inc., New York, NY, USA.
⁵ Takeda Research & Development, Deerfield, IL, USA.
⁶ Neuroscience Therapeutic Area, Takeda Research & Development, Zurich, Switzerland.

PMID: 30940921
DOI: 10.1038/nrd.2018.86

No abstract available

MeSH terms

Alzheimer Disease / therapy*
Big Data*
Humans
Prospective Studies
Research Design
Retrospective Studies